Drug Topics January 24, 2025
Killian Meara, Heather Folz, PharmD, BCACP, Christina H. Sherrill, PharmD, BCACP, BC-ADM

Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM discuss challenges pharmacists may face when implementing CGM services and how they can help raise awareness.

The prevalence of diabetes in the United States continues to grow and research estimates that 54.9 million Americans will have the condition by 2030. This highlights the critical need for both better prevention measures and disease management options such as continuous glucose monitors (CGM). These devices, which have quickly become the standard of care for patients with diabetes, have shown to significantly improve glycemic control.

Drug Topics sat down with Heather Folz, PharmD, BCACP, associate professor of pharmacy practice at Notre Dame of Maryland University and an ambulatory care clinical pharmacist at MedStar...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Digital Health, Interview / Q&A, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Trends, Wearables
Related Articles:
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal
Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity
Ono pays $280M to license Ionis rare disease drug

Share This Article